Hudson Bay Capital Management LP Cytokinetics Inc Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 147,263 shares of CYTK stock, worth $4.46 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
147,263
Previous 141,269
4.24%
Holding current value
$4.46 Million
Previous $6.65 Million
10.94%
% of portfolio
0.02%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$444 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$359 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$301 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$242 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$184 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $2.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...